Navigation Links
Two Pharmaceutical Executives Join TheraQuest Management Team
Date:6/24/2010

BLUE BELL, Pa., June 24 /PRNewswire/ -- TheraQuest Biosciences, Inc., a clinical stage pain management company today announced the appointment of Dr. Danny Kao, PhD, JD, as Senior Vice President, Pharmaceutical Development and General Counsel and Douglas R. Baum, MS as Senior Vice President, Business Development. On June 22, 2010, TheraQuest unveiled its analgesic product pipeline and provided a status update on its lead programs in chronic pain and neuropathic pain.

Dr. Najib Babul, CEO, said, "We have added two seasoned executives with more than 30 years of combined analgesic drug development experience to our senior management team.  The addition of outstanding, multi-talented pharma executives like Danny and Doug is a key step in TheraQuest's evolution as a company. Combined with our new product line-up, this move positions TheraQuest for significant progress in near future."

Biographical Summary of Management Team Additions

Danny Kao, PhD, JD joins TheraQuest as Senior Vice President, Pharmaceutical Development and General Counsel. Previously, Dr. Kao was Director, Strategic Development and Director, Formulation Development at Endo Pharmaceuticals.  Dr. Kao has developed several extended release dosage forms, including first to file generic formulations bioequivalent to OxyContin® and MS Contin®.  Dr. Kao received his master's degree in industrial pharmacy from the St. John's University, New York, his PhD in pharmaceutical sciences from the University of Kentucky and his JD from Touro College Law Center. Dr. Kao is a registered patent attorney at the USPTO and is admitted to practice law in New York and New Jersey.

Douglas R. Baum, MS joins TheraQuest as Senior Vice President, Business Development. Mr. Baum has been involved in analgesic drug development for over 20 years with SCIREX Corporation and with its new corporate entity, Premier Research Group.  He has extensive business development experience, working across a number of classes and formulations of analgesics. Mr. Baum served as VP, Strategic Development in the Analgesia & Rheumatology at SCIREX and later as Senior VP, Early Development Unit and VP, Global Business Development at Premier Research. He has significant operational experience with P&L responsibility, having served as Project Director and Program Director in analgesia. Mr. Baum has authored over 20 scientific publications in the field of pain. He received his bachelor's and master's degree from the University of Texas at Austin.


'/>"/>
SOURCE TheraQuest Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
2. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
3. K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
4. Pharmaceutical Market Research: A Strategic Business Partner in 2011
5. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
6. Effective Social Media Marketing Strategies for Pharmaceutical Market (2010 - 2015): MarketsandMarkets
7. CSafe Signs Master Lease With Cathay Pacific Airways to Further Enhance Healthcare and Pharmaceutical Transport
8. Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference
9. Obamas Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical Devices and Health Insurance)
10. Pharmaceutical and Biotech Executives Must Manage and Optimize Key Opinion Leaders or Fall Behind in the Marketplace
11. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016 --> ... report "Fetal (Labor & Delivery) and Neonatal Care Equipment ... Pulse Oximeter, Phototherapy/Jaundice Management Devices, CPAP, Capnograph, & Resuscitator) ... report studies the global market over the forecast period ... USD 6.28 Billion in 2015 and is poised to ...
(Date:2/4/2016)... For hospitals considering enrollment in the Federal ... the program, the Health Resources and Services Administration,s (HRSA) ... Mega-Guidance , could have significant impact on plans and ... 2016. Essential Insights , Daniel Neal, ... the Mega-Guidance,s key proposed changes, including a new requirement ...
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe A. ... a joint enrollment and degree completion agreement. The agreement, which begins with ... at FHU|Dickson. , The agreement allows students to be jointly admitted to ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter of ... at the La Valencia Hotel in San Diego, California to discuss changes in ... year’s most outstanding franchise, walking away with the coveted David Wright Award of ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Boar’s Head ... just in time for this weekend’s Big Game. Take the stress out of your ... will keep your guests happy at every stage of the game. , “The key ...
(Date:2/5/2016)... ... 05, 2016 , ... Stuart Bentkover, MD, FACS is thrilled to ... the most effective tattoo removal today, Dr. Bentkover is the only doctor in Central ... the PicoSure has been approved by the Food and Drug Administration (FDA) as a ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that ... the event they are experiencing an illness. Migraines are a severe form of a ... with migraines would not wish the pain on their worst enemy, the feeling can ...
Breaking Medicine News(10 mins):